Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 5, 2014-06 ,pp. : 646-650

Bentham Science Publishers

Access to resources Recommend Favorite

Erlotinib in the first-line treatment of non-small-cell lung cancer

By D'Arcangelo Manolo   Cappuzzo Federico  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 5, 2013-05 ,pp. : 523-533

Informa Healthcare

Access to resources Recommend Favorite

The SATURN trial: the value of maintenance erlotinib in patients with non-small-cell lung cancer

By Neal Joel W  

Future Oncology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1827-1832

Future Medicine

Access to resources Recommend Favorite

Maintenance erlotinib improves clinical outcomes of unresectable advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials

By Zhang Jian   Zhang Weiqing   Huang Shaohong   Li Hui   Li Yun   Chen Huiguo   Wu Weibing   Zhou Wei   Wang Cuiping   Liao Hongying   Gu Lijia  

Experimental and Therapeutic Medicine, Vol. 4, Iss. 5, 2012-11 ,pp. : 849-858

Spandidos Publications

Access to resources Recommend Favorite

Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG0803)

By Wu Y.-L.   Zhou C.   Cheng Y.   Lu S.   Chen G.-Y.   Huang C.   Huang Y.-S.   Yan H.-H.   Ren S.   Liu Y.   Yang J.-J.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 993-999

Oxford University Press

Access to resources Recommend Favorite